Mackenzie Financial Corp Has $267.50 Million Stock Holdings in CME Group Inc. (NASDAQ:CME)

Mackenzie Financial Corp lowered its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 6.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,151,866 shares of the financial services provider's stock after selling 76,074 shares during the period. Mackenzie Financial Corp owned about 0.32% of CME Group worth $267,498,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. Peak Retirement Planning Inc. acquired a new stake in CME Group in the fourth quarter valued at $843,000. Parr Mcknight Wealth Management Group LLC acquired a new stake in CME Group in the fourth quarter valued at $3,368,000. GTS Securities LLC lifted its stake in CME Group by 186.2% in the fourth quarter. GTS Securities LLC now owns 3,039 shares of the financial services provider's stock valued at $706,000 after acquiring an additional 6,566 shares during the last quarter. Breed s Hill Capital LLC acquired a new stake in CME Group in the fourth quarter valued at $247,000. Finally, Vise Technologies Inc. lifted its stake in CME Group by 73.3% in the fourth quarter. Vise Technologies Inc. now owns 5,159 shares of the financial services provider's stock valued at $1,198,000 after acquiring an additional 2,182 shares during the last quarter. Institutional investors own 87.75% of the company's stock.

CME Group Price Performance

CME stock traded up $0.29 during mid-day trading on Tuesday, hitting $284.36. The stock had a trading volume of 1,792,736 shares, compared to its average volume of 2,190,079. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $286.48. The firm has a market capitalization of $102.47 billion, a P/E ratio of 29.41, a P/E/G ratio of 6.76 and a beta of 0.45. The firm has a fifty day simple moving average of $268.20 and a 200 day simple moving average of $249.76.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.61 by $0.19. The company had revenue of $1.64 billion during the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The company's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period in the prior year, the business earned $2.50 earnings per share. As a group, research analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be given a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.76%. The ex-dividend date of this dividend is Monday, June 9th. CME Group's dividend payout ratio (DPR) is currently 50.30%.

Insider Buying and Selling at CME Group

In other news, insider Hilda Harris Piell sold 3,984 shares of the company's stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $250.47, for a total value of $997,872.48. Following the sale, the insider now directly owns 27,046 shares of the company's stock, valued at approximately $6,774,211.62. This represents a 12.84% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, COO Suzanne Sprague sold 1,500 shares of the business's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $256.83, for a total transaction of $385,245.00. Following the transaction, the chief operating officer now owns 8,036 shares in the company, valued at $2,063,885.88. The trade was a 15.73% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 28,384 shares of company stock worth $7,531,053. 0.30% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of analysts have commented on the stock. Barclays increased their price target on shares of CME Group from $279.00 to $283.00 and gave the company an "equal weight" rating in a research note on Wednesday, April 23rd. Oppenheimer raised their target price on shares of CME Group from $269.00 to $279.00 and gave the stock an "outperform" rating in a research note on Friday, April 11th. JPMorgan Chase & Co. cut their target price on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research note on Thursday, April 24th. UBS Group raised their target price on shares of CME Group from $290.00 to $305.00 and gave the stock a "buy" rating in a research note on Friday, April 25th. Finally, Piper Sandler raised their target price on shares of CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a research note on Tuesday, April 8th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, CME Group presently has a consensus rating of "Hold" and a consensus price target of $256.80.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.